CompletedPhase 2

Can Parecoxib Reduce Post-operative Ipsilateral Shoulder Pain?

Thailand160 participantsStarted 2011-02

Plain-language summary

The purpose of this study is to compare the efficacy of parecoxib with placebo on the incidence and severity of postthoracotomy shoulder pain, the amount of analgesic requirement for relieving severity of postthoracotomy shoulder pain and adverse events associated with treatment.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * American Society of Anesthesiology (ASA) physical status I-III * Undergoing pulmonary resection by open thoracotomy Exclusion Criteria: * Unable to understand numeric rating scale despite preoperative coaching * Preexisting shoulder pain at the same operative side * Having contraindication for thoracic epidural analgesia * History of previous myocardial ischemia or cerebrovascular accident * Allergic to NSAIDS, sulfonamides or parecoxib * Hepatic or renal impairment * History of current gastrointestinal symptoms * Fluid retention or congestive heart failure * Pregnancy

What they're measuring

Numeric rating scale (NRS) of shoulder pain and incisional pain at rest and movement

Timeframe: at 2 ,6 ,12 ,24 ,48,72 and 96 hours after the operation

Trial details

NCT IDNCT01288924

SponsorChiang Mai University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-10

View on ClinicalTrials.gov More Shoulder Pain trials